Comparison

PF-3758309 European Partner

Item no. TMO-T6626-200mg
Manufacturer TargetMol
CASRN 898044-15-0
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Citations 1. Murray BW, et al. Proc Natl Acad Sci U S A, 2010, 107(20), 9446-9451.
Smiles CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias PF-309,PF-03758309,PF 3758309
Shipping Condition Cool pack
Available
Manufacturer - Targets
PAK|||Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
490.62
Description
PF-3758309 (PF-03758309) (IC50=1.3 nM), a pyrrolopyrazole inhibitor of PAK4, has effective ATP-competition.
Pathways
Cytoskeletal Signaling|||Apoptosis
Bioactivity
PF-03758309 (IC50=1.3 nM), a pyrrolopyrazole inhibitor of PAK4, has effective ATP-competition.
Receptor
PAK1; PAK3; PAK4; PAK5; PAK6

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close